Aclaris Therapeutics (ACRS) Files $300M Mixed Shelf

November 3, 2016 12:03 PM EDT
Get Alerts ACRS Hot Sheet
Trade ACRS Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Aclaris Therapeutics (Nasdaq: ACRS) filed a registration with the U.S. SEC to sell up to $300 million of mixed securities.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Add Your Comment